TaxTMI Login
AI OCR ✕Convert scanned orders, printed notices, PDFs and images into clean, searchable, editable text within seconds. Starting at 2 Credits/page
Try Now →Just a moment...
AI OCR ✕Convert scanned orders, printed notices, PDFs and images into clean, searchable, editable text within seconds. Starting at 2 Credits/page
Try Now →
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
of 
Press 'Enter' after typing page number.
of Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
of Press 'Enter' after typing page number.
of Press 'Enter' after typing page number.
All Case Laws
of Press 'Enter' after typing page number.
of Press 'Enter' after typing page number.
All Case Laws
Note
Bookmark
Share
Don't have an account? Register Here
of Press 'Enter' after typing page number.
Issues: (i) Whether buprenorphine hydrochloride is a psychotropic substance under the Narcotic Drugs and Psychotropic Substances Act, 1985. (ii) Whether possession of buprenorphine hydrochloride by a registered medical practitioner attracts liability under the Narcotic Drugs and Psychotropic Substances Act, 1985 and justifies denial of bail.
Issue (i): Whether buprenorphine hydrochloride is a psychotropic substance under the Narcotic Drugs and Psychotropic Substances Act, 1985.
Analysis: The definition of psychotropic substance covers substances included in the Schedule to the Act. Buprenorphine is specifically listed in the Schedule, and its salts and preparations are also covered. Reading the statutory definition with the Schedule, buprenorphine hydrochloride was treated as a salt of buprenorphine. It therefore falls within the expression psychotropic substance under the Act.
Conclusion: Yes. Buprenorphine hydrochloride is a psychotropic substance under the Act.
Issue (ii): Whether possession of buprenorphine hydrochloride by a registered medical practitioner attracts liability under the Narcotic Drugs and Psychotropic Substances Act, 1985 and justifies denial of bail.
Analysis: Liability under the Act arises only when possession or other dealing is in contravention of the Act, the Rules, or the conditions of any authorization. Section 8 permits medical or scientific use in the manner and to the extent provided by the Act and Rules. The Court found that buprenorphine hydrochloride is not included in Schedule I to the NDPS Rules, so the general prohibitions in Rules 64 to 67 did not apply to it. As a result, its possession, manufacture, sale, and transport were not regulated by the NDPS Rules in the manner alleged, and no contravention of the NDPS Act was established on those facts.
Conclusion: No. The offence under the Act was not made out, and the petitioner was entitled to bail.
Final Conclusion: The petitioner was granted regular bail because the alleged possession of buprenorphine hydrochloride did not constitute an offence under the NDPS Act on the facts found.
Ratio Decidendi: Possession of a psychotropic substance is punishable only when it is shown to be in contravention of the Act or the applicable Rules, and a substance not covered by the relevant NDPS Rules cannot be treated as offending possession under the alleged regulatory prohibition.
TaxTMI 
TaxTMI 
